产品货号：
JN1717
中文名称：
重组人激肽释放酶(Kallikrein 1)(KLK1)
英文名称：
Recombinant Human Kallikrein 1
产品规格：
10μg|50μg|500μg|1mg
发货周期：
1～3天
产品价格：
询价
本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Pro19-Ser262在C端含有His标签。
Kallikrein 1质量控制：＞95%(还原性SDS-PAGE)
Kallikrein 1制剂：液体
Kallikrein 1保存：收到货后请置于-20℃，可保存6个月，避免反复冻融。
关于Kallikrein 1：
Kallikrein-1 (KLK1) is a member of human tissue Kallikrein family. Human KLK1 precursor contains a singal peptide (residues 1 to 18), a short pro peptide (residues 19 to 24) and a mature chain (residues 25 to 262). The function of KLK1 is to cleave Kininogen in order to release the vasoactive Kinin peptide (Lysyl-Bradykinin or Bradykinin). The Kinin peptide controls blood pressure reduction, vasodilation, smooth muscle relaxation and contraction, pain induction and inflammation. KLK1 also plays a role in angiogensis and tumorigenesis.
相关搜索：重组人激肽释放酶(Kallikrein 1)(KLK1)，Recombinant Human Kallikrein 1
Kallikrein 1质量控制：＞95%(还原性SDS-PAGE)
Kallikrein 1制剂：液体
Kallikrein 1保存：收到货后请置于-20℃，可保存6个月，避免反复冻融。
关于Kallikrein 1：
Kallikrein-1 (KLK1) is a member of human tissue Kallikrein family. Human KLK1 precursor contains a singal peptide (residues 1 to 18), a short pro peptide (residues 19 to 24) and a mature chain (residues 25 to 262). The function of KLK1 is to cleave Kininogen in order to release the vasoactive Kinin peptide (Lysyl-Bradykinin or Bradykinin). The Kinin peptide controls blood pressure reduction, vasodilation, smooth muscle relaxation and contraction, pain induction and inflammation. KLK1 also plays a role in angiogensis and tumorigenesis.
相关搜索：重组人激肽释放酶(Kallikrein 1)(KLK1)，Recombinant Human Kallikrein 1